Page
%P
-
Article
Open AccessCarfilzomib and the cardiorenal system in myeloma: an endothelial effect?
Carfilzomib (Cfz) has been associated with an ~5% incidence of unexplained and unpredictable cardiovascular toxicity in clinical trials. We therefore implemented a detailed, prospective, clinical cardiac and r...